However, genetic evidence argues these tumors mostly originate from cutaneous sites, as they demonstrate a similar distribution of BRAF, NRAS and NF1 mutations to cutaneous melanoma [22]. The gene discussed is NRAS; the disease is cutaneous melanoma.